Saisheng Pharmaceutical (300485.SZ): The company is not involved in the vaccine business

Gelonghui, May 27 | Saisheng Pharmaceutical (300485.SZ) said on the investor interactive platform that the company's shareholding company Luzhu Biotech is a company whose main research direction is human vaccines and therapeutic bifunctional antibody drugs. Please check its official and statutory disclosure information websites for relevant information. The company is not involved in the vaccine business.

Gelonghui FinanceMay 27 03:59 ET

Saisheng Pharmaceutical (300485.SZ) plans to pay 0.22 yuan for 10 shares to be deducted from interest on May 29

Saisheng Pharmaceutical (300485.SZ) announced that the company's 2023 equity distribution plan: to all shareholders for every 10...

Zhitong FinanceMay 22 04:58 ET

Saisheng Pharmaceutical (300485.SZ): It has genetic engineering and biological extraction technology, and can be applied to synthetic biology. Currently, the company is not involved in this business

Gelonghui, May 8 | Saisheng Pharmaceutical (300485.SZ) said on the investor interactive platform that the company has genetic engineering and biological extraction technology, which can be applied to synthetic biology. Currently, the company is not involved in this business. Among the investment projects initiated by the company, 3 companies involved synthetic biology: Shanxi Kaisheng Biotechnology Co., Ltd., Chengdu Yatu Biotechnology Co., Ltd., and Like Times (Wuhan) Biotechnology Co., Ltd.

Gelonghui FinanceMay 8 03:56 ET

Saisheng Pharmaceutical (300485.SZ): Net loss of 190 million yuan in the first quarter turned into a year-on-year loss

On April 25, Gelonghui | Saisheng Pharmaceutical (300485.SZ) released its first quarter report. Operating revenue was 110 million yuan, down 17.46% year on year, net loss was 190 million yuan, turning loss year on year. After deducting non-net profit of 15.1578 million yuan, up 383.81% year on year, and basic earnings per share -0.3957 yuan.

Gelonghui FinanceApr 25 03:59 ET

Saisheng Pharmaceutical (300485.SZ): As of April 10, 2024, the number of shareholders of the company was 31,397

Gelonghui, April 12 | Saisheng Pharmaceutical (300485.SZ) said on the investor interactive platform that as of April 10, 2024, the number of shareholders of the company was 31,397.

Gelonghui FinanceApr 12 04:37 ET

Saisheng Pharmaceutical (300485.SZ): Net profit for 2023 decreased by 49.73% to 103 million yuan, plans to distribute 10 to 0.22 yuan

Gelonghui, April 9 | Saisheng Pharmaceutical (300485.SZ) announced its 2023 annual report. In 2023, the company achieved operating income of 477 million yuan, a year-on-year decrease of 35.12%; net profit attributable to shareholders of listed companies was 103 million yuan, a year-on-year decrease of 49.73%; net profit attributable to shareholders of listed companies after deducting non-recurring gains and losses; basic earnings per share of 0.21 yuan; it plans to distribute a cash dividend of 0.22 yuan (tax included) for every 10 shares to all shareholders.

Gelonghui FinanceApr 9 05:01 ET